CIENCIASMEDICASNEWS: Medical News | Medical Articles | Targeted screening effective in reducing prostate cancer deaths

viernes, 10 de enero de 2020

Medical News | Medical Articles | Targeted screening effective in reducing prostate cancer deaths

	Prostate Cancer
	The latest prostate cancer news from News Medical

Targeted screening effective in reducing prostate cancer deaths

A new study published in the journal PLOS Medicine shows that the number of prostate cancer deaths could be reduced by a sixth by simply introducing targeted screening, which is directed at detecting cases among men whose genes put them at higher risk of the disease.

			Prostate cancer risk linked to assisted reproduction techniques A study published in BMJ has revealed a link between the risk of prostate cancer and men who have become fathers via assisted reproduction techniques.

			National veteran dataset will help dissect the relationship between mental illness and prostate cancer There appears to be an unhealthy synergy between mental illness and prostate cancer, and researchers are working to dissect the relationship by first assembling the largest dataset ever of veterans with either condition or both.

	Prostate cancer deaths are on the rise, shows new ACS report Despite most cancers seeing a drop in deaths, prostate cancer deaths are on the rise in the U.S. New reporting from the American Cancer Society shows that in 2020, the number of men who will die from prostate cancer will hit a record high over the last two decades, with an increase of 5 percent since just last year.

	Can Curcumin Prevent or Treat Prostate Cancer? Aggressive prostate cancer cannot be treated effectively by current medical or surgical therapies of radical prostatectomy, chemotherapy, radiotherapy, or androgen deprivation therapy.

	Unique biomarker in urine may offer non-invasive means of detecting prostate cancer A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene.

	Scientists find driver for more deadly prostate cancer A transcription factor that aids neuron function also appears to enable a cell conversion in the prostate gland that can make an already recurrent cancer even more deadly, scientists say.